BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33486711)

  • 1. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis?
    Guilbaud T; Girard E; Lemoine C; Schlienger G; Alao O; Risse O; Berdah S; Chirica M; Moutardier V; Birnbaum DJ
    Updates Surg; 2021 Apr; 73(2):439-450. PubMed ID: 33486711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis.
    Muttillo EM; Ciardi A; Troiano R; Saullo P; Masselli G; Guida M; Tortora A; Sperduti I; Marinello G; Chirletti P; Caronna R
    World J Surg Oncol; 2021 Jan; 19(1):10. PubMed ID: 33430887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The true prognosis of resected distal cholangiocarcinoma.
    Courtin-Tanguy L; Rayar M; Bergeat D; Merdrignac A; Harnoy Y; Boudjema K; Meunier B; Sulpice L
    J Surg Oncol; 2016 Apr; 113(5):575-80. PubMed ID: 26776934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinomas of the distal bile duct].
    Bahra M; Langrehr JM; Neuhaus P
    Chirurg; 2006 Apr; 77(4):335-40. PubMed ID: 16523255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
    Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
    Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
    Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
    Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
    Byrling J; Ghazi S; Andersson B
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.
    Macfie R; Berger Y; Liu H; Li T; Imtiaz S; Ang C; Sarpel U; Hiotis S; Labow D; Golas B; Cohen NA
    Ann Surg Oncol; 2023 Aug; 30(8):5027-5034. PubMed ID: 37210446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Timing of Systemic Therapy and Postoperative Morbidity in Resectable Pancreatic Ductal Adenocarcinoma and Distal Cholangiocarcinoma.
    Macfie R; Cohen N
    Ann Surg Oncol; 2023 Aug; 30(8):5035. PubMed ID: 37179272
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mid-bile duct carcinoma: Local resection or pancreatoduodenectomy?
    Schreuder AM; Engelsman AF; van Roessel S; Verheij J; Besselink MG; van Gulik TM; Busch OR
    Eur J Surg Oncol; 2019 Nov; 45(11):2180-2187. PubMed ID: 31279596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
    Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
    J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma.
    Maeta T; Ebata T; Hayashi E; Kawahara T; Mizuno S; Matsumoto N; Ohta S; Nagino M;
    Br J Surg; 2017 Oct; 104(11):1549-1557. PubMed ID: 28782798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
    Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
    Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.